Acute Management of Stroke

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 19

Acute Management of Stroke

Dr Amri Masri
June 2011
Race against time
• Treatment and stabilisation of patient.
• Specific therapy:
– Recanalisation
– Neuroprotection
• Acute complications:
– Secondary haemorrhage, oedema, seizures, aspiration,
infections, ulcers, DVTs, PE.
• Early secondary prevention.
• Early rehabilitation.
Penumbra
Emergency diagnostic tests in acute stroke.

• Brain imaging CT or MRI.


• ECG.
• FBC, Clotting profile.
• Serum electrolytes.
• Blood glucose.
• Hepatic and renal parameters.
• CRP or ESR.
The decision:
To thrombolyse or not…
Ischaemic Stroke Thrombolysis

• Inclusion:
– Clinical diagnosis of ischaemic stroke with recognisable
neurological deficits.
– *Within 4.5hrs.
– *Seizures at stroke onset but must be clear the seizure is
due to cerebral ischaemia.
– *Age 18-80 yrs.
– *Haemorrhage excluded by CT.
– Consent to treat.
Ischaemic Stroke Thrombolysis

• Exclusion:
– Beyond 4.5hrs.
– Severe neurological deficit NIHSS > 25.
– Stroke within last 3 mths.
– Traumatic brain injury last 3 mths.
– MI last 3 mths.
– GI/GU bleeding last 3 weeks.
– Larger surgical interventions last 2 weeks.
– Symptoms suggestive of SAH even if CT is normal.
– Arterial puncture in non-compressible site.
Ischaemic Stroke Thrombolysis

• Exclusion(cont’):
– Large stroke in CT >1/3 of hemisphere.
– Intracerebral bleeding in history.
– Diabetes and stroke in history.
– On oral anticoagulation, INR must be <1.5.
– Heparin in the last 48hrs, aPTT <40s, Platelets >100
– Uncontrolled BP, must be <185/110
– Dysglycaemia <3 or >22 mmol/L
– Acute pancreatitis.
– Endocarditis.
rtPA- Actilyse

• 0.9mg/kg, maximum dose of 90mg.


• Give 10% of dose as bolus then the remaining as
infusion over 1hr.
Thrombolysis SOP
• 2 large bore cannulas both antecubital veins before
thrombolysis.
• Catheterise before thrombolysis.
• No invasive procedures, IM injections after thrombolysis.
• No FH, LMWH, antiplatelets 24hrs after thrombolysis.
• Beware of anaphylaxis, bleeding.
• If headache, nausea, vomiting, acute BP increase stop
thrombolysis and repeat CT.
• 24hrs bed rest.
• Repeat CT 24-48hrs after thrombolysis.
Monitoring parameters: Airway and Respiratory

• Airway protection.
• Risk of aspiration.
• Maintain adequate oxygenation for preservation of
penumbra.
• Continuous SpO2 monitoring at least 24-48hrs.
Monitoring parameters: Cardiovascular

• Continuous heart rate monitoring.


• Prior HTN 180/100-105.
• Without prior HTN 160-180/90-100.
• Thrombolysed patient BP <185/110.
• Avoid nifedipine SL and drastic BP reduction.
• Immediate antihypertensive therapy in concomittant
medical problems e.g. ICH, cardiac failure, ACS,
aortic dissection, hypertensive encephalopathy.
• Avoid and treat hypotension: fluids, volume
expanders, catecholamines.
Monitoring Parameters: Blood glucose

• Keep blood glucose <10mmol/L.


• Avoid hypo or hyperglycaemia- associated with
poor functional outcomes.
• Hypoglycaemia may mimic stroke.
Monitoring parameters: Body temperature

• Hyperthermia associated with larger infarcts and


poor outcome.
• Could be centrally driven or exogenous.
• Search for infection and treat.
• Temperature <37.5 degrees C.
Monitoring parameters: Fluid and electrolytes

• Balanced electrolyte and fluid status important to


avoid:
– Hypo/hypervolaemia.
– Plasma volume contraction.
– Raised haematocrit.
• Avoid hypotonic fluids.
Anticoagulation

• For DVT prophylaxis.


• No benefit on stroke outcome.
• However, selected indications for full dose heparin
e.g. cardiac sources with high risk of re-embolism,
high grade arterial stenosis.
THE END

You might also like